Författare: David F. Kisor

Dave Kisor, Professor of Pharmaceutical Sciences and Pharmaco genomics and Director of Pharmacogenomics, joined Manchester University in June 2014 and is responsible for directing pharmacogenomics across programs in the College of Pharmacy, Natural and Health Sciences. He led the development and implementation of the first dedicated Master of Pharmacogenomics Program (MS in PGx) in the United States, helping to expand delivery to an online format, as well as helping to establish the first Pharm D/MS in PGx dual degree program. He received his Bachelor of Science degree in Pharmacy from The University of Toledo and his Doctorate in Pharmacy from The Ohio State University. He completed a postdoctoral fellowship in therapeutic drug monitoring and pharmacokinetics at Ohio State. He has integrated pharmacogenetics and pharmacogenomics with pharmacokinetic subject matter since 1998. Beyond the formal academic setting, he is very engaged in pharmacogenomics education, having been involved with the American Association of Colleges of Pharmacy Pharmacogenomics Special Interest Group (AACP PGx SIG) in defining/refining competency statements for pharmacists as well as leading the effort to provide the first certification program in pharmacogenomics in the United States. He is a member of the American Pharmacists Association (APh A), the American College of Clinical Pharmacology (ACCP), the American Society for Clinical Pharmacology and Therapeutics (ASCPT), the American Association of Colleges of Pharmacy (AACP), and the Clinical Pharmaco genetics Implementation Consortium (CPIC). Dr. Kisor is a past chair of the AACP PGx SIG. He was named a fellow of ACCP in 2017.